Business Context and Reporting Period
This Form 8-K is filed by Anthem, Inc. (now Elevance Health, Inc.) on January 14, 2002. The report discloses an upcoming meeting between company officers and securities analysts/investors scheduled for the week of January 14, 2002.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The report references a press release from November 14, 2001, which contained earnings expectations, but does not restate those figures within this document.
Material Changes
No material changes to financial results or operations are reported in this filing. The document serves solely to announce the upcoming investor meetings and reiterate the company's expectation to meet previously disclosed earnings guidance.
Guidance, Outlook, and Risks
Management expects to confirm its ability to meet the earnings expectations provided in the November 14, 2001 press release. The filing includes a standard caution regarding forward-looking statements, noting that actual results may differ due to various risks, including:
- Trends in health care costs and utilization rates.
- Ability to secure sufficient premium rate increases.
- Competitor pricing strategies below market trends.
- Increased government regulation of health benefits and managed care.
- Significant acquisitions or divestitures by major competitors.
- Introduction and utilization of new prescription drugs and technology.
- Potential downgrade in financial strength ratings.
- Litigation targeted at health benefits companies.
- Ability to contract with providers consistent with past practice.
- General economic downturns.
Investor Verification Checklist
- Verify the specific earnings expectations detailed in the November 14, 2001 press release (filed as Exhibit 99 to the prior 8-K).
- Review the company's final Prospectus dated October 29, 2001, for the initial public offering.
- Examine periodic reports (Form 10-K, 10-Q, and 8-K) for detailed financial data and risk factors.
- Monitor upcoming analyst meetings for any updates to the forward-looking statements.